Concepedia
Statistics
Publications
8
Citations
340
H-Index
Active since
1984
Affiliations
Mayo Clinic(Current)
Kimberly L. Kooistra is an author at Mayo Clinic specializing in medicine, oncology, and pharmacology.
Publications per year
1984–1993
EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
Hans R. Hendriks, P. E. Pizao, Dan Berger et al. · European Journal of Cancer · 1993 · 104 citations · Full text
Medicine, Oncology, Pharmacology +7
New Xenograft Model for Assessing Experimental Therapy of Central Nervous System Tumors: Human Glioblastoma in the Intrathecal Compartment of the Nude Mouse
Chad D. Abernathey, Kimberly L. Kooistra, George L. Wilcox et al. · Neurosurgery · 1988 · 54 citations
Medicine, Cancer Biology, Oncology +16
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines.
Michael C. Alley, Garth Powis, Peggy Appel et al. · PubMed · 1984 · 49 citations
Medicine, Oncology, Pharmacology +17
Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kimberly L. Kooistra, Moses Rodriguez, Garth Powis et al. · PubMed · 1986 · 44 citations
Medicine, Oncology, Metastasis +10
Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodents
Paul Workman, M. BINGER, Kimberly L. Kooistra · International Journal of Radiation Oncology*Biology*Physics · 1992 · 35 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +7
1–5 of 8